Literature DB >> 21129630

Emerging carbapenemases: a global perspective.

Timothy R Walsh1.   

Abstract

The celestial rise in antibiotic resistance among Gram-negative bacteria has challenged both the scientific and pharmaceutical sectors. The hallmark of this general increase is the unbridled dissemination of carbapenem resistance genes, namely KPC, OXA and metallo-β-lactamase variants. In particular, the media attention given to the NDM-1 metallo-β-lactamase has highlighted the global consequences of human behaviour on spreading antibiotic resistance.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21129630     DOI： 10.1016/S0924-8579(10)70004-2

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


  143 in total

1.  Crystal structure of the mobile metallo-β-lactamase AIM-1 from Pseudomonas aeruginosa: insights into antibiotic binding and the role of Gln157.

Authors:  Hanna-Kirsti S Leiros; Pardha S Borra; Bjørn Olav Brandsdal; Kine Susann Waade Edvardsen; James Spencer; Timothy R Walsh; Orjan Samuelsen
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom.

Authors:  Michael Hornsey; Lynette Phee; David W Wareham
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

Review 3.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

4.  Emergence of OXA-48-type carbapenemase-producing Enterobacteriaceae in German hospitals.

Authors:  Yvonne Pfeifer; Kathrin Schlatterer; Elisabeth Engelmann; Reinhold A Schiller; Hans Reiner Frangenberg; Doris Stiewe; Martin Holfelder; Wolfgang Witte; Patrice Nordmann; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

5.  Diverse sequence types of Klebsiella pneumoniae contribute to the dissemination of blaNDM-1 in India, Sweden, and the United Kingdom.

Authors:  Christian G Giske; Inga Fröding; Chowdhury Mehedi Hasan; Agata Turlej-Rogacka; Mark Toleman; David Livermore; Neil Woodford; Timothy R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2012-02-21       Impact factor: 5.191

6.  Detection of carbapenemases in Enterobacteriaceae by a commercial multiplex PCR.

Authors:  Martin Kaase; Florian Szabados; Lars Wassill; Sören G Gatermann
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

Review 7.  Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones.

Authors:  Louis B Rice
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

8.  Real-time PCR assays for the detection and quantification of carbapenemase genes (bla KPC, bla NDM, and bla OXA-48) in environmental samples.

Authors:  Jèssica Subirats; Elena Royo; José Luis Balcázar; Carles M Borrego
Journal:  Environ Sci Pollut Res Int       Date:  2017-01-13       Impact factor: 4.223

9.  Detection of Antibiotic Resistance Determinants and Their Transmissibility among Clinically Isolated Carbapenem-Resistant Escherichia coli from South India.

Authors:  Niranjana Mahalingam; Bhavani Manivannan; Balaram Khamari; Shivakumara Siddaramappa; Sudeshna Adak; Eswarappa Pradeep Bulagonda
Journal:  Med Princ Pract       Date:  2018-05-08       Impact factor: 1.927

Review 10.  Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae.

Authors:  Agnese Lupo; Krisztina M Papp-Wallace; Parham Sendi; Robert A Bonomo; Andrea Endimiani
Journal:  Diagn Microbiol Infect Dis       Date:  2013-10-03       Impact factor: 2.803
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.